Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Non-Current Assets: 2023-2024

Historic Non-Current Assets for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $43.2 million.

  • Zhengye Biotechnology Holding's Non-Current Assets was N/A to $41.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $41.9 million, marking a year-over-year change of. This contributed to the annual value of $43.2 million for FY2024, which is 1.61% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Non-Current Assets stood at $43.2 million for FY2024, which was down 1.61% from $44.0 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Non-Current Assets high stood at $44.0 million for FY2023, and its period low was $43.2 million during FY2024.
  • For the 2-year period, Zhengye Biotechnology Holding's Non-Current Assets averaged around $43.6 million, with its median value being $43.6 million (2023).
  • Data for Zhengye Biotechnology Holding's Non-Current Assets shows a maximum YoY fell of 1.61% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Non-Current Assets (Yearly) stood at $44.0 million in 2023, then fell by 1.61% to $43.2 million in 2024.